Home Tools
Log in
Cart

RSV

Human orthopneumovirus (also known as human respiratory syncytial virus, or HRSV, or just RSV) is a syncytial virus that causes respiratory tract infections.
Signaling Pathways | Target | TargetMol
Cat. No. Product name CAS No. Purity Chemical Structure
T5539 GS-443902 1355149-45-9
GS-443902
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at lea...
T79217 RSV L-protein-IN-2 774130-99-3 98%
RSV L-protein-IN-2
RSV L-protein-IN-2 (Compound A), a noncompetitive inhibitor of the RSV polymerase (IC50: 4.5 μM), exhibits antiviral activity against long RSV strains (EC50: 1.3...
T79219 RSV L-protein-IN-3 868860-35-9 98%
RSV L-protein-IN-3
RSV L-protein-IN-3 is an inhibitor of the wild-type RSV polymerase, exhibiting an IC50 of 10.4 μM and an EC50 of 2.1 μM (against RSV), and possesses lower cytoto...
T79220 RSV L-protein-IN-4 851657-60-8 98%
RSV L-protein-IN-4
RSV L-protein-IN-4 (Compound C) is a noncompetitive inhibitor of the RSV polymerase with an IC50 of 0.88 μM. It demonstrates potent antiviral activity against RS...
T79221 RSV L-protein-IN-5 851658-28-1 98%
RSV L-protein-IN-5
RSV L-protein-IN-5 (Compound E) serves as a potent inhibitor of the Respiratory Syncytial Virus (RSV), with an EC50 value of 0.1 μM. It targets RSV polymerase wi...
T82005 JNJ-8003 98%
JNJ-8003
JNJ-8003 is a potent inhibitor of RSV Polymerase, effectively impeding the early stages of RNA transcription and replication by inhibiting nucleotide polymerizat...
TQ0034 Lumicitabine 1445385-02-3 98%
Lumicitabine
Lumicitabine (ALS-008176) is an inhibitor of RSV polymerase.
T77100 Nirsevimab 1989556-22-0 SDS-PAGE:98.2%;SEC-HPLC:98.1%
Nirsevimab
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region. Nirsevimab efficiently targets RSV-...
T76992 Suptavumab 1629615-23-1 SDS-PAGE:96.3%;SEC-HPLC:99.2%
Suptavumab
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab neutralizes conserved epitopes on subtypes A and B on RSV. Suptavumab can be used to study RSV i...
T76907 Palivizumab 188039-54-5 SDS-PAGE:93.4%;SEC-HPLC:97.6%
Palivizumab
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and...
T26914 BTA-9881 1646857-24-0 99.86%
BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
T0684 Ribavirin 36791-04-5 99.83%
Ribavirin
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses.
T15621 Rilematovir 1383450-81-4 99.82%
Rilematovir
Rilematovir (JNJ-678) is an inhibitor of fusion protein with antiviral activity and low cytotoxicity. Rilematovir can be used in studies about respiratory syncyt...
T4380 Ac-CoA Synthase Inhibitor1 508186-14-9 99.81%
Ac-CoA Synthase Inhibitor1
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2).
T1024 Roflumilast 162401-32-3 99.64%
Roflumilast
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplast...
T9197 Sisunatovir hydrochloride 1903763-83-6 99.49%
Sisunatovir hydrochloride
Sisunatovir hydrochloride (RV521 HCl) is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolat...
T11760 KIN101 610753-87-2 99.46%
KIN101
KIN101 (3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene), an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KI...
T60016 VV116 2647442-33-7 99.42%
VV116
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection.
TQ0085 Presatovir 1353625-73-6 99.38%
Presatovir
Presatovir (GS-5806) (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM).
T3417 Amentoflavone 1617-53-4 99.22%
Amentoflavone
Amentoflavone (3',8''-Biapigenin), as a potent inhibitor of CYP3A4 and CYP2C9, can interact with many other medications. CYP3A4 and CYP2C9 are proteins used for ...
GS-443902
T5539
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at lea...
RSV L-protein-IN-2
T79217
RSV L-protein-IN-2 (Compound A), a noncompetitive inhibitor of the RSV polymerase (IC50: 4.5 μM), exhibits antiviral activity against long RSV strains (EC50: 1.3...
RSV L-protein-IN-3
T79219
RSV L-protein-IN-3 is an inhibitor of the wild-type RSV polymerase, exhibiting an IC50 of 10.4 μM and an EC50 of 2.1 μM (against RSV), and possesses lower cytoto...
RSV L-protein-IN-4
T79220
RSV L-protein-IN-4 (Compound C) is a noncompetitive inhibitor of the RSV polymerase with an IC50 of 0.88 μM. It demonstrates potent antiviral activity against RS...
RSV L-protein-IN-5
T79221
RSV L-protein-IN-5 (Compound E) serves as a potent inhibitor of the Respiratory Syncytial Virus (RSV), with an EC50 value of 0.1 μM. It targets RSV polymerase wi...
JNJ-8003
T82005
JNJ-8003 is a potent inhibitor of RSV Polymerase, effectively impeding the early stages of RNA transcription and replication by inhibiting nucleotide polymerizat...
Lumicitabine
TQ0034
Lumicitabine (ALS-008176) is an inhibitor of RSV polymerase.
Nirsevimab
T77100
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region. Nirsevimab efficiently targets RSV-...
Suptavumab
T76992
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab neutralizes conserved epitopes on subtypes A and B on RSV. Suptavumab can be used to study RSV i...
Palivizumab
T76907
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and...
BTA-9881
T26914
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Ribavirin
T0684
Ribavirin (Tribavirin) is a synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses.
Rilematovir
T15621
Rilematovir (JNJ-678) is an inhibitor of fusion protein with antiviral activity and low cytotoxicity. Rilematovir can be used in studies about respiratory syncyt...
Ac-CoA Synthase Inhibitor1
T4380
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2).
Roflumilast
T1024
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplast...
Sisunatovir hydrochloride
T9197
Sisunatovir hydrochloride (RV521 HCl) is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolat...
KIN101
T11760
KIN101 (3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene), an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KI...
VV116
T60016
VV116 (JT001) is a selective and orally active nucleoside antiviral agent against respiratory syncytial virus (RSV) and SARS-CoV-2 infection.
Presatovir
TQ0085
Presatovir (GS-5806) (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM).
Amentoflavone
T3417
Amentoflavone (3',8''-Biapigenin), as a potent inhibitor of CYP3A4 and CYP2C9, can interact with many other medications. CYP3A4 and CYP2C9 are proteins used for ...
1 2
TargetMol